NCT00474058 - Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine | Biotech Hunter

Enrollment

287

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Parkinson's Disease

Interventions

DRUG

Rotigotine

"Rotigotine transdermal patches:~10cm2 (2mg/24h); 20cm2 (4mg/24h); 30cm2 (6mg/24h); 40cm2 (8mg/24h)~Optimal dosing: The maximum Rotigotine dose allowed is 16mg/24h"

OTHER

Placebo

Placebo transdermal patches

Trial Locations (47)

6020

Innsbruck

10713

Berlin

12163

Berlin

28144

Salisbury

33701

St. Petersburg

34128

Kassel

35039

Marburg

66013

Chieti

89081

Ulm

90220

Oulu

Unknown

Reseda

Ventura

Winston_Salem

Warwick

Houston

Concord

Adelaide

Fitzroy

Hyvinkää

Leipzig

Naumburg

Budapest

Debrecen

Nyíregyháza

Zalaegerszeg

Milan

Torino

Christchurch

Wellington

Gdansk

Krakow

Lublin

Olsztyn

Szczecin

Warsaw

Cape Town

Capetown

Johannesburg

Pretoria/Gauteng

Tygerberg

Madrid

Bristol

Lancashire

Liverpool

London

01307

Dresden

08036

Barcelona